Vycor Medical (VYCO) EBITDA Margin (2010 - 2026)
Vycor Medical (VYCO) reported EBITDA Margin of 4.39% for Q1 2026, up 1322.0% year-over-year from 0.31% in Q1 2025, and up 129.16% on a QoQ basis from 15.04% in Q4 2025.
Vycor Medical (VYCO) has 17 years of EBITDA Margin data on file, last reported at 4.39% in Q1 2026.
- Quarterly EBITDA Margin rose 1322.0% year-over-year to 4.39% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.73% (up 609.0% YoY) and the FY2025 annual result came in at 3.89%, up 286.0% from the prior year.
- EBITDA Margin rose to 4.39% in Q1 2026 per VYCO's latest filing, from 15.04% in the prior quarter.
- Across five years, EBITDA Margin topped out at 14.17% in Q2 2023 and bottomed at 42.96% in Q4 2022.
- The 5-year median for EBITDA Margin is 9.08% (2024), against an average of 12.17%.
- Peak annual rise in EBITDA Margin reached 5838 bps in 2022, while the deepest fall reached 3815 bps in 2022.
- Tracing VYCO's EBITDA Margin over 5 years: stood at 42.96% in 2022, then increased by 30 bps to 30.19% in 2023, then soared by 95 bps to 1.48% in 2024, then slumped by 916 bps to 15.04% in 2025, then surged by 129 bps to 4.39% in 2026.
- Per Business Quant, the three latest VYCO EBITDA Margin figures stand at 4.39% (Q1 2026), 15.04% (Q4 2025), and 0.96% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.94% |
| 10 | Vycor Medical | - | - | 375,153.00 | 4.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.39% |
| Dec 31, 2025 | -15.04% |
| Sep 30, 2025 | 0.96% |
| Jun 30, 2025 | 4.81% |
| Mar 31, 2025 | -8.84% |
| Dec 31, 2024 | -1.48% |
| Sep 30, 2024 | -15.30% |
| Jun 30, 2024 | -2.47% |
| Mar 31, 2024 | -9.08% |
| Dec 31, 2023 | -30.19% |
| Sep 30, 2023 | -16.82% |
| Jun 30, 2023 | 14.17% |
| Mar 31, 2023 | 1.90% |
| Dec 31, 2022 | -42.96% |
| Sep 30, 2022 | -37.04% |
| Jun 30, 2022 | -30.19% |
| Mar 31, 2022 | -23.75% |
| Dec 31, 2021 | -68.34% |
| Sep 30, 2021 | 1.11% |
| Jun 30, 2021 | -1.91% |
| Mar 31, 2021 | -82.13% |
| Dec 31, 2020 | -68.71% |
| Sep 30, 2020 | -71.86% |
| Jun 30, 2020 | -101.89% |
| Mar 31, 2020 | -52.98% |
| Dec 31, 2019 | -66.66% |
| Sep 30, 2019 | -64.92% |
| Jun 30, 2019 | -31.69% |
| Mar 31, 2019 | -46.44% |
| Dec 31, 2018 | -109.02% |
| Sep 30, 2018 | -29.09% |
| Jun 30, 2018 | -137.54% |
| Mar 31, 2018 | -100.83% |
| Dec 31, 2017 | -138.81% |
| Sep 30, 2017 | -112.56% |
| Jun 30, 2017 | -118.20% |
| Mar 31, 2017 | -73.01% |
| Dec 31, 2016 | -141.00% |
| Sep 30, 2016 | -101.42% |
| Jun 30, 2016 | -79.71% |
| Mar 31, 2016 | -153.94% |
| Dec 31, 2015 | -153.68% |
| Sep 30, 2015 | -201.94% |
| Jun 30, 2015 | -140.27% |
| Mar 31, 2015 | -275.84% |
| Sep 30, 2014 | -382.21% |
| Jun 30, 2014 | -426.23% |
| Mar 31, 2014 | -219.89% |
| Dec 31, 2013 | -196.84% |
| Sep 30, 2013 | -157.61% |
| Jun 30, 2013 | -232.41% |
| Mar 31, 2013 | -231.65% |
| Dec 31, 2012 | -162.94% |
| Sep 30, 2012 | -317.87% |
| Jun 30, 2012 | -255.02% |
| Mar 31, 2012 | -162.41% |
| Dec 31, 2011 | -167.93% |
| Sep 30, 2011 | -392.98% |
| Jun 30, 2011 | -1,297.37% |
| Mar 31, 2011 | -655.22% |
| Dec 31, 2010 | -803.40% |
| Sep 30, 2010 | -488.22% |
| Jun 30, 2010 | -545.85% |